Sign in Register

Drug class

Thalidomide and Derivative Immunomodulators

Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells. Read more about Thalidomide and Derivative Immunomodulators

30 drugs in this class 21 manufacturers

Related classes & indications

Alkylating AgentsOncology & immunomodulators · 192 prescription drugs Antirheumatic Agents (DMARDS, non-Biologic)Oncology & immunomodulators · 179 prescription drugs Multiple MyelomaTop indication · 167 prescription drugs

Showing 19–27 of 30 drugs

Sort

LENALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6

DEVATIS, INC.

LENALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6

Amneal Pharmaceuticals

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

AUROBINDO PHARM

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

BRECKENRIDGE

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

TEVA PHARM

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

CAMBER PHARMACE

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

APOTEX CORP

ZENBEXUS (iberdomide HCl)

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA

BMS PRIMARYCARE

POMALIDOMIDE

THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1

DR.REDDY'S LAB

Filter & compare in the drug finder → Opens the drug finder with Thalidomide and Derivative Immunomodulators preselected. Add indication or manufacturer filters there.

About Thalidomide and Derivative Immunomodulators.

Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells.

These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors.

Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum.

brainkart.com
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions su...
nih.gov
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
nih.gov
Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum
jddonline.com
Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum